Literature DB >> 19172228

Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin.

Fabiano C Tanuri1, Eliângela de Lima, Mario F P Peres, Francisco R Cabral, Maria da Graça Naffah-Mazzacoratti, Esper Abrão Cavalheiro, José Cipolla-Neto, Eliova Zukerman, Débora Amado.   

Abstract

The aim of the present work was to analyze c-fos response within the trigeminal nucleus caudalis (TNC) of pinealectomized rats and animals that received intraperitoneal melatonin, after intracisternal infusion of capsaicin, used to induce intracranial trigeminovascular stimulation. Experimental groups consisted of animals that received vehicle solution (saline-ethanol-Tween 80, 8:1:1, diluted 1:50) only (VEI, n=5); animals that received capsaicin solution (200 nM) only (CAP, n=6); animals submitted to pinealectomy (PX, n=5); sham-operated animals (SH, n=5); animals submitted to pinealectomy followed by capsaicin stimulation (200 nM) after 15 days (PX + CAP, n=7); and animals that received capsaicin solution (200 nM) and intraperitoneal melatonin (10 mg/kg) (CAP + MEL, n=5). Control rats, receiving vehicle in the cisterna magna, showed a small number of c-fos-positive cells in the TNC (layer I/II) as well as the sham-operated and pinealectomized rats, when compared to animals stimulated by capsaicin. On the other hand, pinealectomized rats, which received capsaicin, presented the highest number of c-fos-positive cells. Animals receiving capsaicin and melatonin treatment had similar expression of the vehicle group. Our data provide experimental evidence to support the role of melatonin and pineal gland in the pathophysiology of neurovascular headaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172228      PMCID: PMC3451652          DOI: 10.1007/s10194-009-0097-3

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  40 in total

1.  Technique for collecting cerebrospinal fluid in the cisterna magna of non-anesthetized rats.

Authors:  A R Consiglio; A B Lucion
Journal:  Brain Res Brain Res Protoc       Date:  2000-02

2.  CIOMS International Guiding Principles for Biomedical Research Involving Animals.

Authors: 
Journal:  Altern Lab Anim       Date:  1985-06       Impact factor: 1.303

3.  Melatonin, 3 mg, is effective for migraine prevention.

Authors:  M F P Peres; E Zukerman; F da Cunha Tanuri; F R Moreira; J Cipolla-Neto
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

4.  Trigeminal nociception-induced cerebral Fos expression in the conscious rat.

Authors:  G J Ter Horst; W J Meijler; J Korf; R H Kemper
Journal:  Cephalalgia       Date:  2001-12       Impact factor: 6.292

5.  Melatonin in the preventive treatment of chronic cluster headache.

Authors:  M F Peres; T D Rozen
Journal:  Cephalalgia       Date:  2001-12       Impact factor: 6.292

Review 6.  Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine.

Authors:  D D Mitsikostas; M Sanchez del Rio
Journal:  Brain Res Brain Res Rev       Date:  2001-03

Review 7.  Pathophysiology of migraine--new insights.

Authors:  R J Hargreaves; S L Shepheard
Journal:  Can J Neurol Sci       Date:  1999-11       Impact factor: 2.104

8.  Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry.

Authors:  M R Mayberg; N T Zervas; M A Moskowitz
Journal:  J Comp Neurol       Date:  1984-02-10       Impact factor: 3.215

Review 9.  Rare nocturnal headaches.

Authors:  Anna S Cohen; Holger Kaube
Journal:  Curr Opin Neurol       Date:  2004-06       Impact factor: 5.710

10.  Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor.

Authors:  Antonio Carrillo-Vico; Sofía García-Mauriño; Juan R Calvo; Juan M Guerrero
Journal:  FASEB J       Date:  2003-02-19       Impact factor: 5.191

View more
  3 in total

1.  Regulatory mechanism of melatonin on the retinal ganglion cell photoreaction in mice.

Authors:  Jianqiao Li; Jiongwan Hong; Fang Zhou; Shibo Tang; Xinyi Wu
Journal:  Exp Ther Med       Date:  2017-06-26       Impact factor: 2.447

2.  Melatonin in antinociception: its therapeutic applications.

Authors:  Venkatramanujam Srinivasan; Edward C Lauterbach; Khek Yu Ho; Dario Acuña-Castroviejo; Rahimah Zakaria; Amnon Brzezinski
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

Review 3.  The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System.

Authors:  Cheong-Meng Chong; Zhangfeng Zhong; Chi Teng Vong; Shengpeng Wang; Jin-Jian Lu; Hai-Jing Zhong; Huanxing Su; Yitao Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.